The global nanopore technologies market size reached USD 308.0 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 786.5 Million by 2033, exhibiting a growth rate (CAGR) of 11% during 2025-2033.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024
|
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024
|
USD 308.0 Million |
Market Forecast in 2033
|
USD 786.5 Million |
Market Growth Rate 2025-2033 | 11% |
Nanopore technology refers to the next-generation molecule sequencing of single-molecule deoxyribonucleic acid (DNA) without the need for polymerase chain reaction (PCR) amplification and chemical labeling of the sample. It offers a relatively high throughput and low-cost genotyping, high mobility for testing, rapid processing of samples in real-time, and label-free, ultralong reads. It is used as a diagnostic tool to provide a fast analysis, eliminate cumbersome amplification and conversion steps, and detect target molecules at very low concentrations and screen panels of biomarkers or genes. Nowadays, the read quality of nanopore technology has improved significantly on account of the introduction of advanced nanopore proteins and chemistries.
The outbreak of the coronavirus disease (COVID-19), in confluence with the urgent need to develop a potential treatment, represents one of the key factors driving the need for nanopore technologies worldwide. Researchers are extensively relying on these technologies to generate data, ranging from initial characterization of the virus genome to the rapid identification of variants, essential to combating the spread of the pandemic. Apart from this, the increasing prevalence of cancer among a significant part of the population due to the rising number of individuals who smoke, drink, and have obesity and chronic inflammation is contributing to the market growth. Nanopore technologies are used in oncology settings for facilitating cancer diagnosis and treatment through the detection and accurate quantification of microRNA. In addition, leading market players are introducing a new generation of sensing technology that uses nanopores embedded in high-tech electronics to perform precise molecular analyses. This technology is gaining widespread adoption in applied settings, such as clinical diagnostics, epidemiology, food safety, agriculture, and environmental science. Such innovations are projected to influence the market positively.
IMARC Group provides an analysis of the key trends in each sub-segment of the global nanopore technologies market report, along with forecasts at the global, regional and country level from 2025-2033. Our report has categorized the market based on product, application and end user.
Breakup by Product:
Breakup by Application:
Breakup by End User:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., Cyclomics BV, Electronic Biosciences Inc., Inanobio Inc., Nabsys Inc., Ontera Inc., Oxford Nanopore Technologies Limited, Pacific Biosciences of California Inc., Quantapore Inc., Roche Holding AG and Tracxn Technologies Limited.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Million USD |
Segment Coverage | Product, Application, End User, Region |
Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Agilent Technologies Inc., Cyclomics BV, Electronic Biosciences Inc., Inanobio Inc., Nabsys Inc., Ontera Inc., Oxford Nanopore Technologies Limited, Pacific Biosciences of California Inc., Quantapore Inc., Roche Holding AG and Tracxn Technologies Limited |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
The global nanopore technologies market was valued at USD 308.0 Million in 2024.
We expect the global nanopore technologies market to exhibit a CAGR of 11% during 2025-2033.
The rising utilization of nanopore technologies in oncology settings for facilitating cancer diagnosis and treatment through the detection and accurate quantification of microRNA is primarily driving the global nanopore technologies market.
The sudden outbreak of the COVID-19 pandemic has led to the growing adoption of nanopore technology to generate initial characterization of the coronavirus-infection genome and rapid identification of its variants and develop a potential treatment to combat its spread through human intervention.
Based on the product, the global nanopore technologies market can be divided into instruments and consumables. Currently, consumables exhibit a clear dominance in the market.
Based on the application, the global nanopore technologies market has been categorized into DNA sequencing, RNA sequencing, and others. Among these, DNA sequencing currently accounts for the majority of the global market share.
Based on the end user, the global nanopore technologies market can be segregated into hospitals and clinics, research institutes, and others. Currently, research institutes hold the largest market share.
On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global nanopore technologies market include Agilent Technologies Inc., Cyclomics BV, Electronic Biosciences Inc., Inanobio Inc., Nabsys Inc., Ontera Inc., Oxford Nanopore Technologies Limited, Pacific Biosciences of California Inc., Quantapore Inc., Roche Holding AG, and Tracxn Technologies Limited.